Medication Adherence in Epileptic Children Follows Socioeconomic Status

The investigators limited their focus to sociodemographic and medical factors. In addition, they did not study whether adherence trajectories affected health outcomes. However, this study is part of a longitudinal study, and the investigators noted that they are "currently examining psychosocial factors that contribute to adherence trajectories."

The study was funded by a grant from the National Institutes of Health. Dr. Modi disclosed that she has been a consultant for Novartis Pharmaceuticals Inc. Another study author disclosed speaker and adviser relationships with companies that manufacture antiepileptic drugs.